These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma. Satomi K; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Narita Y; Ichimura K; Yoshida A Mod Pathol; 2021 Apr; 34(4):688-700. PubMed ID: 33077924 [TBL] [Abstract][Full Text] [Related]
3. Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas. Marker DF; Pearce TM Acta Neuropathol Commun; 2020 Oct; 8(1):169. PubMed ID: 33081848 [TBL] [Abstract][Full Text] [Related]
4. IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations. Yang RR; Shi ZF; Zhang ZY; Chan AK; Aibaidula A; Wang WW; Kwan JSH; Poon WS; Chen H; Li WC; Chung NY; Punchhi G; Chu WC; Chan IS; Liu XZ; Mao Y; Li KK; Ng HK Brain Pathol; 2020 May; 30(3):541-553. PubMed ID: 31733156 [TBL] [Abstract][Full Text] [Related]
5. T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant. Onishi S; Kojima M; Yamasaki F; Amatya VJ; Yonezawa U; Taguchi A; Ozono I; Go Y; Takeshima Y; Hiyama E; Horie N Neurosurg Rev; 2024 Aug; 47(1):412. PubMed ID: 39117984 [TBL] [Abstract][Full Text] [Related]
6. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors]. Wang SN; Wang W; Zhang XW; Zhang YQ; Xiong YL; Liu L; Teng LH Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):439-445. PubMed ID: 38678323 [No Abstract] [Full Text] [Related]
12. Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study. Park YW; Park KS; Park JE; Ahn SS; Park I; Kim HS; Chang JH; Lee SK; Kim SH Korean J Radiol; 2023 Feb; 24(2):133-144. PubMed ID: 36725354 [TBL] [Abstract][Full Text] [Related]
13. IDH-mutant astrocytoma with an evolutional progression to CDKN2A/B homozygous deletion and NTRK fusion during recurrence: A case report. Kirishima M; Akahane T; Higa N; Suzuki S; Ueno S; Yonezawa H; Uchida H; Hanaya R; Yoshimoto K; Shimajiri S; Kitazono I; Tanimoto A Pathol Res Pract; 2022 Nov; 239():154163. PubMed ID: 36265224 [TBL] [Abstract][Full Text] [Related]